Neurosense Therapeutics Ltd. (NRSN)
Market Open
12 Jun, 14:47
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
0. 74
+0
+0.1353%
$
18.75M Market Cap
- P/E Ratio
- Div Yield
33,059 Volume
-0.8 Eps
$ 0.74
Previous Close Investors:
Want to track NRSN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurosense Therapeutics Ltd. (NRSN) Statistics
Valuation metrics
Market Cap 18.75M
Enterprise value 18.51M
Trailing P/E (ttm) -2.93
Forward P/E -
PEG ratio 0.75
Price/Sales (ttm) -
Price/Book (mrq) -12.21
Enterprise Value/Revenue -
Enterprise Value/EBITDA -2.87
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 101.85K
Average volume (90 days) 155.23K
Price summary
52-Week low 0.63
52-Week high 2.52
Beta -
50-Day moving average 0.81
200-Day moving average 0.88
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -6.33%
Return on equity 1,736%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.01
Total debt (mrq) -
Total Debt/Equity (mrq) -0.11
Current ratio (mrq) 0.31%
Book value per share (mrq) -0.06
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
